Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J. Kerr

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
BMC Cancer|May 18, 2012
EnROL: a multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programmeRobin H Kennedy, Anne Francis, Susan Dutton, et al.
The American Journal of Pathology|September 18, 2010
Roles of tetrahydrobiopterin in promoting tumor angiogenesisLiye Chen, Xin Zeng, Jihui Wang, et al.
Journal of Surgical Oncology|February 16, 2018
The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trialAnouck Huijbers, Gabi W van Pelt, Rachel S Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancerEnric Domingo, David N Church, Oliver Sieber, et al.
Cancer Gene Therapy|May 29, 2002
Identification of FGF receptor-binding peptides for cancer gene therapyFukuto Maruta, Alan L Parker, Kerry D Fisher, et al.
Histopathology|June 26, 2021
Stromal composition predicts recurrence of early rectal cancer after local excisionHelen J S Jones, Chris Cunningham, Hanne A Askautrud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicinLeonard W Seymour, David R Ferry, David Anderson, et al.
Journal of Drug Targeting|May 10, 2007
Bacteriophage biopanning in human tumour biopsies to identify cancer-specific targeting ligandsFukuto Maruta, Noriyuki Akita, Jun Nakayama, et al.
Lancet (London, England)|February 8, 2003
Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trialDavid J Kerr, Colin S McArdle, Jonathan Ledermann, et al.
International Journal of Cancer|December 18, 2019
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancerElin Ersvaer, Tarjei S Hveem, Ljiljana Vlatkovic, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
BMC Cancer|May 18, 2012
EnROL: a multicentre randomised trial of conventional versus laparoscopic surgery for colorectal cancer within an enhanced recovery programmeRobin H Kennedy, Anne Francis, Susan Dutton, et al.
The American Journal of Pathology|September 18, 2010
Roles of tetrahydrobiopterin in promoting tumor angiogenesisLiye Chen, Xin Zeng, Jihui Wang, et al.
Journal of Surgical Oncology|February 16, 2018
The value of additional bevacizumab in patients with high-risk stroma-high colon cancer. A study within the QUASAR2 trial, an open-label randomized phase 3 trialAnouck Huijbers, Gabi W van Pelt, Rachel S Kerr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancerEnric Domingo, David N Church, Oliver Sieber, et al.
Cancer Gene Therapy|May 29, 2002
Identification of FGF receptor-binding peptides for cancer gene therapyFukuto Maruta, Alan L Parker, Kerry D Fisher, et al.
Histopathology|June 26, 2021
Stromal composition predicts recurrence of early rectal cancer after local excisionHelen J S Jones, Chris Cunningham, Hanne A Askautrud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicinLeonard W Seymour, David R Ferry, David Anderson, et al.
Journal of Drug Targeting|May 10, 2007
Bacteriophage biopanning in human tumour biopsies to identify cancer-specific targeting ligandsFukuto Maruta, Noriyuki Akita, Jun Nakayama, et al.
Lancet (London, England)|February 8, 2003
Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trialDavid J Kerr, Colin S McArdle, Jonathan Ledermann, et al.
International Journal of Cancer|December 18, 2019
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancerElin Ersvaer, Tarjei S Hveem, Ljiljana Vlatkovic, et al.
Pageof 9